Showing results (541-550 of 726) with videos related to
Sort By:
Pageof 73
Annals of Surgical Oncology|January 8, 2020
Evaluation of the 12-Gene Molecular Score and the 21-Gene Recurrence Score as Predictors of Response to Neo-adjuvant Chemotherapy in Estrogen Receptor-Positive, HER2-Negative Breast CancerHatem Soliman, Susanne Wagner, Darl D Flake, et al.Journal of Immunology (Baltimore, Md. : 1950)|January 22, 2005
Kinase-independent functions for Itk in TCR-induced regulation of Vav and the actin cytoskeletonDerek Dombroski, Richard A Houghtling, Christine M Labno, et al.Cancer Management and Research|June 6, 2017
APF530 versus ondansetron, each in a guideline-recommended three-drug regimen, for the prevention of chemotherapy-induced nausea and vomiting due to anthracycline plus cyclophosphamide-based highly emetogenic chemotherapy regimens: a post hoc subgroup analysis of the Phase III randomized MAGIC trialIan D Schnadig, Richy Agajanian, Christopher Dakhil, et al.Oncotarget|May 1, 2018
Molecular profiling of advanced breast cancer tumors is beneficial in assisting clinical treatment plansPhilip Carter, Costi Alifrangis, Biancastella Cereser, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 29, 2013
Phase 2 study of pemetrexed plus carboplatin, or pemetrexed plus cisplatin with concurrent radiation therapy followed by pemetrexed consolidation in patients with favorable-prognosis inoperable stage IIIA/B non-small-cell lung cancerHak Choy, Lee S Schwartzberg, Shaker R Dakhil, et al.Physical Review Letters|January 5, 2024
Polariton Condensation in Gap-Confined States of Photonic Crystal WaveguidesF Riminucci, A Gianfrate, D Nigro, et al.The Journal of Allergy and Clinical Immunology. Global|October 2, 2023
Eosinophil trafficking in allergen-mediated pulmonary inflammation relies on IL-13-driven CCL-11 and CCL-24 production by tissue fibroblasts and myeloid cellsPedro H Gazzinelli-Guimaraes, Dominic P Golec, Erik P Karmele, et al.Oncotarget|March 31, 2018
Correction: Does molecular profiling of tumors using the Caris molecular intelligence platform improve outcomes for cancer patients?Philip Carter, Costi Alifrangis, Biancastella Cereser, et al.The Oncologist|June 2, 2020
Eflapegrastim, a Long-Acting Granulocyte-Colony Stimulating Factor for the Management of Chemotherapy-Induced Neutropenia: Results of a Phase III TrialLee S Schwartzberg, Gajanan Bhat, Julio Peguero, et al.Nature Medicine|February 16, 2005
Regulation of NKT cell development by SAP, the protein defective in XLPKim E Nichols, Jamie Hom, Shun-You Gong, et al.Pageof 73